Tenderwize
Retour à la recherche

Supply of medical devices for parenteral access

GCS UniHA·LYON, France·EUR 426.6M·Deadline Apr 21, 2033 · 2435 days left·Restricted·Supplies·DPS
Inscrivez-vous pour sauvegarder
High valueStructured notice only
Titre original de l'avis

France – Medical consumables – UniHA_Fourniture de dispositifs médicaux de l’abord parentéral – PAR24 - M_2917

50/100

Score d'opportunité

Needs reviewMedium complexity
SuppliesDPSOpen
Pourquoi ce score ?

Opportunité

50 / 100

Complexité

35 / 100

Facteurs de risque

Inconsistency between structured data (isEuFunded=true) and XML notice (no-eu-funds). This may affect contract conditio...

Essential details such as exact eligibility criteria, award criteria, and required documents are missing, increasing bi...

Restricted procedure — pre-qualification required

Analyse approfondie du portefeuille

Analyse approfondie de l'adéquation entreprise

Utilise:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Aperçu

Moderate opportunity

Faits clés

  • EUR 426.6M estimated value
  • Dynamic Purchasing System (DPS)
  • Supplies contract
  • 1 lot
  • Duration 120 MONTH
  • Supply of medical devices for parenteral access
  • Scope includes infusion supplies, syringes, catheters, medical needles, anesthesia needles, and related consumables
Afficher le résumé complet

This tender is a Dynamic Purchasing System (DPS) for the supply of medical devices for parenteral access (dispositifs médicaux de l'abord parentéral) to member institutions of GCS UniHA. The DPS has a single lot with an estimated value of EUR 426,593,580 over 120 months. The procedure is restricted, and candidatures are selected based on economic, financial, and professional capacity criteria (article 7.2 of the RC). The DPS is open until 21 April 2033. The notice is a corrigendum of the original notice 23-54605, modifying the consultation address.

Risques

Inconsistency between structured data (isEuFunded=true) and XML notice (no-eu-funds). This may affect contract conditio...

Essential details such as exact eligibility criteria, award criteria, and required documents are missing, increasing bi...

Restricted procedure — pre-qualification required

No procurement documents available

L'analyse peut être incomplète

Seule une partie des documents de consultation a été analysée. Des exigences, certificats ou documents de soumission supplémentaires peuvent exister dans les documents restants.

Exigences clés

Technical

  • DPS admission based on economic, financial, and professional capacity (article 7.2 of RC)
  • No limit on the number of candidates admitted
  • Admission decision within 10 working days (15 if additional information requested)

Les exigences peuvent être incomplètes.

Acheteur

Localisation

LYON, FRA

Profil acheteur

Ouvrir le profil

Identifiant

130 002 223 00043

Activité

Health

Lots (1)

LOT-0001

Supply of medical devices for parenteral access

Supply of medical devices for parenteral access (infusion supplies, syringes, catheters, needles, etc.) for UniHA member establishments. This lot covers the entire scope of the DPS.

SuppliesDPSEU fundedElectronic submissionSME suitable

EUR 426.6M

Valeur estimée

Localisation

FRK26, France

Durée

120 MONTH

Catégorie

Medical consumables

Date limite

Deadline Apr 21, 2033

Détails de la procédure

Date de publication
18 Jun 2026
Langues
French

Métadonnées de référence

Base juridique
32014L0024

Identifiants de référence

ID de l'appel d'offres
422555-2026

Documents (1)

Portail de soumission 1

Appels d'offres similaires

Belgium – Pharmaceutical products – Antimycotica

Aug 27

France – Pharmaceutical products – 26-10 : ACCORD-CADRE DE FOURNITURE DE MÉDICAMENTS 2026

Aug 21

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Ipratropiumbromid (ATC-Code nach WHO: R03BB01)

Sep 30

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Oralair(R) (ATC-Code nach WHO: V01AA02)

Aug 31

Bulgaria – Pharmaceutical products – Динамична система за покупки за доставка на лекарствени продукти за Медицински институт на МВР

Jul 9

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Orylmyte(R) (ATC-Code nach WHO: V01AA03)

Aug 31